Pamplona Capital Management nears deal to buy Parexel - WSJ

Pamplona Capital Management nears deal to buy Parexel - WSJ


Private equity firm Pamplona Capital Management is nearing a deal to buy contract drug research firm Parexel International Corp for $4.6 billion, the Wall Street Journal reported on Tuesday. Pamplona is set to pay $88.10 a share in cash as part of the deal, the newspaper said citing people familiar with the matter.



from Biotech News